Trials / Unknown
UnknownNCT06280430
Vascular Affection in Behcet Disease
Serum Elafin :A Biomarker in Behcet Disease and Its Relation to Vascular Involvement and Disease Activity
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 90 (estimated)
- Sponsor
- Assiut University · Academic / Other
- Sex
- All
- Age
- 20 Years – 45 Years
- Healthy volunteers
- —
Summary
To measure the level of serum elafin in patients with behcet disease and to assess the correlation between serum elafin and vascular affection and their relation with disease activity
Detailed description
Behcet disease is a chronic multi systemic inflammatory disease characterized by recurrent oral and genital ulcers and multiple systemic affection . Elafin is a serine protease inhibitor produced mainly by epithelial cells . previous studies documented the role of serum elafin in pathogenesis of behcet disease.vascular complications may be one if the earliest manifestation leading to the diagnosis of behcet disease.
Conditions
Timeline
- Start date
- 2024-03-01
- Primary completion
- 2025-03-01
- Completion
- 2025-04-01
- First posted
- 2024-02-28
- Last updated
- 2024-02-28
Source: ClinicalTrials.gov record NCT06280430. Inclusion in this directory is not an endorsement.